2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
70
TL;DR: In 2018, the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2018 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions as discussed by the authors .
read more
Abstract: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelines will provide useful and sensible advice for the clinical management of patients with HCC. A total of 49 experts in the fields of hepatology, oncology, surgery, radiology, and radiation oncology from the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2018 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions. These guidelines provide useful information and direction for all clinicians, trainees, and researchers in the diagnosis and treatment of HCC.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide.
25 Mar 2024
TL;DR: Changing etiology and epidemiology of hepatocellular carcinoma: HCC is primarily caused by HBV infection, but the incidence of HCC related to NASH and NAFLD has increased worldwide.
42
Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Yuri Cho,Jin Woo Choi,Hoon Kwon,Kun Yung Kim,Byung Chan Lee,Hee Ho Chu,Dong Hyeon Lee,Gyoung Min Kim,Jung Suk Oh,Dongho Hyun,In Joon Lee,Hyunchul Rhim +11 more
TL;DR: In this article , a group of 12 experts in the fields of interventional radiology and hepatology, convened by the Research Committee of the Korean Liver Cancer Association (KLCA), has developed expert consensus-based practical recommendations in TACE.
27
Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and MR imaging.
TL;DR: In this paper , the authors evaluated the prognostic value of microvascular invasion (MVI) classification and analyzed the radiologic features predictive of MVI in hepatocellular carcinoma (HCC) patients.
Radiologic features of hepatocellular carcinoma related to prognosis
Shin Hye Hwang,Hyungjin Rhee +1 more
TL;DR: Examination of imaging findings related to the prognosis of HCC as well as their associated clinicopathological characteristics is reviewed to decide the treatment strategy for HCC.
11
Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives
Joo Hyun Oh,Dong Hyun Sinn +1 more
TL;DR: Multidisciplinary approach for HCC management is promising, but lacks robust evidence and requires increased resources.
References
Diagnostic value of deep learning reconstruction for radiation dose reduction at abdominal ultra-high-resolution CT
TL;DR: In this article, the authors evaluated lower dose (LD) hepatic dynamic ultra-high-resolution computed tomography (UHRCT) images reconstructed with deep learning reconstruction (DLR), hybrid iterative reconstruction (hybrid-IR), or model-based IR (MBIR) in comparison with standard-dose (SD) U-HRCT image reconstructed with hybrid-IR as the reference standard to identify the method that allowed for the greatest radiation dose reduction while preserving the diagnostic value.
Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria.
TL;DR: In this article, living-donor liver transplantation represents a treatment option for hepatocellular carcinoma and liver transplant offers the most reasonable expectation for curative treatment for liver cancer.
Emergency transarterial embolization followed by staged hepatectomy versus emergency hepatectomy for ruptured hepatocellular carcinoma: a single-center, propensity score matched analysis
TL;DR: For resectable ruptured HCC, emergency TAE of rupture which followed by SH, could bring patients about intraoperative and postoperative benefits when compared to EH, and might achieve favorable survival benefits for patients.
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.
Tim Meyer,Tim Meyer,Richard Fox,Yuk Ting Ma,Paul Ross,Paul Ross,Martin W. James,Martin W. James,R Sturgess,Clive Stubbs,Deborah D. Stocken,Lucy Wall,A. Watkinson,Nigel Hacking,T.R. Jeffry Evans,Peter William Collins,Richard A Hubner,David Cunningham,John N. Primrose,Philip J. Johnson,Daniel H. Palmer,Daniel H. Palmer +21 more
TL;DR: In this paper, a multikinase inhibitor sorafenib was used to improve progression-free survival in patients with intermediate stage hepatocellular carcinoma compared to TACE with placebo.
Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging.
Masahiro Tanabe,Akihiko Kanki,Tanya Wolfson,Eduardo A. C. Costa,Adrija Mamidipalli,Marilia P. F. D. Ferreira,Cynthia Santillan,Michael S. Middleton,Anthony Gamst,Yuko Kono,Alexander Kuo,Claude B. Sirlin +11 more
TL;DR: Observations classified according to LI-RADS version 2014 categories are associated with different imaging outcomes.
Related Papers (5)
T. Hasegawa,Nobuyuki Takemura,Tatsuya Yamashita,Takeyuki Watadani,Masaki Kaibori,Shoji Kubo,M Shimada,Hiroaki Nagano,Etsuro Hatano,Hiroshi Aikata,Hiroko Iijima,Kazuomi Ueshima,Kazuyoshi Ohkawa,Takuya Genda,Kaoru Tsuchiya,Takuji Torimura,Masafumi Ikeda,Junji Furuse,Masaaki Akahane,Satoshi Kobayashi,Hideyuki Sakurai,Atsuya Takeda,Takamichi Murakami,Utaroh Motosugi,Yutaka Matsuyama,Masatoshi Kudo,Ryosuke Tateishi +26 more